Buthainah Alhwarat

Researcher

UAMS primary UA Little Rock

Also affiliated: University of Nevada, Las Vegas (2023); University of Nevada, Reno (2023); Hashemite University (2023); University of Tennessee Health Science Center (2023); University of Arkansas Medical Center (2025); Central Arkansas Veterans Healthcare System (2026); University Medical Center of Southern Nevada (2023); Arkansas Department of Agriculture (2026)

Faculty Researcher

1 h-index 15 pubs 1 cited

Research Areas

OverviewAI-generated summary

Buthainah Alhwarat's research centers on cardiovascular health outcomes, with a particular focus on real-world data analysis. Her work investigates the impact of various therapeutic interventions and patient characteristics on cardiovascular events. Recent publications examine the real-world cardiovascular outcomes of SGLT2 inhibitor and GLP1 receptor agonist therapy in individuals with type 2 diabetes, as well as the outcomes of GLP-1RA therapy in obese non-diabetic patients with metabolic dysfunction-associated steatotic liver disease. Alhwarat has also studied the cardioprotective effects of beta-blocker therapy post-myocardial infarction and the association between coronary in-stent restenosis and adverse cardiovascular events in renal transplant recipients. Her research also includes a systematic review on the representation of women in atrial fibrillation clinical trials and an analysis of post-traumatic stress disorder and major cardiovascular outcomes. She collaborates with researchers including Robert Spraggins, Subhi Al'Aref, Subhi J. Al’Aref, and Bhupendar Tayal at the University of Arkansas for Medical Sciences.

Metrics

h-index: 1
Publications: 15
Citations: 1

Selected Publications

AI-enhanced ECG for acute coronary syndrome triage: A state-of-the-art review (2026)

Cardiovascular revascularization medicine DOI OpenAlex
Representation of Women in Atrial Fibrillation Clinical Trials: A Systematic Review (2026)

Reviews in Cardiovascular Medicine DOI OpenAlex
26-A-11242-ACC REAL-WORLD CARDIOVASCULAR OUTCOMES OF COMBINED SGLT2 INHIBITOR AND GLP1 RECEPTOR AGONIST THERAPY IN TYPE 2 DIABETES INDIVIDUALS (2026)

Journal of the American College of Cardiology DOI OpenAlex
26-A-15959-ACC CARDIOVASCULAR OUTCOMES OF GLP-1RA THERAPY IN OBESE NON-DIABETIC PATIENTS WITH METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE: A REAL-WORLD ANALYSIS (2026)

Journal of the American College of Cardiology DOI OpenAlex
1200.03 Real-World Cardiovascular Outcomes of Inclisiran Versus PCSK9 Monoclonal Antibodies Therapy in Individuals with Hyperlipidemia (2026)

JACC: Cardiovascular Interventions DOI OpenAlex
TCT-200 Association between the Occurrence of Coronary In-Stent Restenosis in Post-Renal Transplant Recipients and Adverse Cardiovascular Events (2025)

Journal of the American College of Cardiology DOI OpenAlex
TCT-415 Cardiovascular Outcomes in Individuals Undergoing Percutaneous Coronary Intervention with or without a Preceding Coronary CT Angiogram: A Comparison Using Real World Data (2025)

Journal of the American College of Cardiology DOI OpenAlex
TCT-262 Five-Year Mortality Comparison of Left Ventricular Unloading Devices for Individuals with Cardiogenic Shock on VA-ECMO (2025)

Journal of the American College of Cardiology DOI OpenAlex
Dislodged Right Ventricular Pacemaker Lead Detected Incidentally Two Years Post-implantation via Echocardiography: A Case Report (2025)

Cureus DOI OpenAlex
Contemporary Practices for Management of Subclinical Atrial Fibrillation (2025)

Journal of Clinical Medicine DOI OpenAlex
Role of Medication Reconciliation in Managing Bradycardia: A Rare Cause of Medication-Induced Sinus Bradycardia (2025)

Cureus DOI OpenAlex